GlassScriptPhysician profile
Timothy Clark
NPI 1629027974
$2,010.40
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,295 · 2022: $702 · 2024: $13.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $476.02 | 2021-2022 | |
| Novo Nordisk INC | $335.62 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $191.95 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $175.49 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $166.62 | 2021-2022 | |
| Pfizer INC. | $76.96 | 2021-2024 | |
| Biohaven Pharmaceuticals, INC. | $65.19 | 2021 | |
| Merck Sharp & Dohme LLC | $64.89 | 2021 | |
| Amarin Pharma, INC. | $57.45 | 2021 | |
| Sanofi-Aventis U.S. LLC | $56.15 | 2021-2022 | |
| Lilly USA, LLC | $53.74 | 2021 | |
| Sanofi Pasteur INC. | $53.58 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $48.44 | 2021-2022 | |
| Astellas Pharma US INC | $48.27 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $34.06 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $22.82 | 2022 | |
| Nestle Healthcare Nutrition INC. | $20.25 | 2021 | |
| Esperion Therapeutics, INC. | $16.43 | 2021 | |
| Glaxosmithkline, LLC. | $16.11 | 2021 | |
| Amgen INC. | $15.79 | 2021 | |
| Genentech USA, INC. | $14.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.